JACC-Cardiovascular Interventions
Scope & Guideline
Unveiling the Future of Cardiac Care
Introduction
Aims and Scopes
- Transcatheter Valve Interventions:
This area covers innovations and outcomes related to transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair/replacement, and tricuspid valve interventions, showcasing techniques like edge-to-edge repair and valve-in-valve procedures. - Coronary Intervention Techniques:
Research in this scope addresses the development and optimization of percutaneous coronary interventions (PCI), including the use of drug-coated balloons, stent technologies, and techniques for chronic total occlusion (CTO) recanalization. - Cardiovascular Imaging and Guidance:
This focus area emphasizes the role of imaging modalities such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and computed tomography (CT) in guiding interventional procedures and assessing outcomes. - Clinical Outcomes and Risk Assessment:
This scope includes studies on the prognostic implications of various interventions, patient selection criteria, and risk models for patients undergoing interventional procedures, particularly in high-risk groups. - Transcatheter Therapies for Structural Heart Disease:
Research on the application of transcatheter techniques for structural heart disease management, including edge-to-edge repairs and valve replacements in various anatomical and pathological contexts. - Innovative Technologies and Devices:
The journal highlights the development of novel devices and technologies, including new stent designs, delivery systems, and adjunctive therapies aimed at improving procedural safety and effectiveness.
Trending and Emerging
- Integration of Artificial Intelligence:
There is a growing interest in the application of artificial intelligence (AI) for predicting outcomes, guiding interventions, and personalizing treatment plans, indicating a technological shift in cardiology. - Minimally Invasive Techniques:
Research focusing on minimally invasive procedures, particularly in the context of transcatheter interventions, is on the rise, reflecting a broader trend towards reducing patient morbidity. - Patient Selection and Personalized Medicine:
There is an increasing emphasis on the importance of personalized medicine in interventional cardiology, with studies exploring how specific patient characteristics influence treatment outcomes. - Use of Novel Biomarkers:
Emerging research is focusing on new biomarkers for predicting patient outcomes and guiding therapy, indicating a trend towards more tailored cardiovascular interventions. - Comprehensive Assessment of Valve Disease:
An increased focus on the comprehensive assessment of valve disease, including multi-valve involvement and the integration of various treatment modalities, is becoming more prominent in recent publications.
Declining or Waning
- Conventional Surgical Techniques:
There is a noticeable decline in research focused on traditional surgical techniques for valve replacements, as the field moves towards less invasive transcatheter approaches. - Long-term Outcomes of Older Devices:
As newer technologies and devices gain prominence, studies focusing on older devices and their long-term outcomes are becoming less frequent, indicating a shift towards evaluating contemporary solutions. - Basic Cardiovascular Physiology Studies:
Research that purely focuses on basic cardiovascular physiology without direct application to interventional techniques is less frequently represented, as the emphasis shifts towards clinical applications and outcomes. - Single-Center Studies:
There seems to be a decline in single-center studies, as multicenter and larger registry studies are preferred for their robustness and generalizability. - Generic Comparisons of Antiplatelet Therapies:
Comparative studies on generic antiplatelet therapies are less common as more complex, individualized approaches to treatment emerge, prioritizing patient-specific factors.
Similar Journals
Cardiovascular Revascularization Medicine
Transforming Cardiovascular InterventionsCardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.
Journal of Cardiovascular Medicine
Elevating Standards in Cardiovascular MedicineWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.
CORONARY ARTERY DISEASE
Connecting global experts to enhance cardiovascular care.CORONARY ARTERY DISEASE, published by Lippincott Williams & Wilkins, stands as a vital contributor to the field of cardiology and cardiovascular medicine. Established in 1990, this esteemed journal presents cutting-edge research and insights from internationally recognized experts, facilitating the advancement of knowledge on coronary artery diseases. With its current impact factor placing it in the Q3 category for both Cardiology and Cardiovascular Medicine as well as miscellaneous Medicine, this journal is a valuable resource for researchers, healthcare professionals, and students alike, eager to stay abreast of developments in this critical area of health. Although it does not offer open access, articles published within its pages continue to influence clinical practice and healthcare strategies significantly. Situated at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, the journal engages a global audience, maintaining a commitment to showcasing innovative research until at least 2024. Engage with CORONARY ARTERY DISEASE to enhance your understanding and foster progress in cardiovascular health.
Cardiology Journal
Championing open access to vital cardiology research.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
EuroIntervention
Connecting Research and Clinical Excellence in CardiologyEuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.
Heart International
Connecting researchers and clinicians in the pursuit of heart health.Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.
Minerva Cardiology and Angiology
Exploring the frontiers of cardiology and vascular science.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
Netherlands Heart Journal
Leading the Way in Cardiovascular Research and PracticeNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
TEXAS HEART INSTITUTE JOURNAL
Illuminating the Future of Cardiovascular Medicine.TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.
Heart Views
Pioneering insights in cardiology for global impact.Heart Views is a prestigious and influential journal dedicated to the field of cardiology and cardiovascular medicine, published by Wolters Kluwer Medknow Publications. With an Open Access model implemented since 2010, the journal ensures that its valuable research findings are accessible to a global audience, fostering knowledge dissemination and collaboration among researchers, professionals, and students alike. While the current impact factor is not specified, its commitment to quality and peer-reviewed content has established it as a significant resource within the cardiology community. The journal publishes a diverse array of articles, including original research, reviews, and clinical studies aimed at advancing the understanding and treatment of cardiovascular diseases. Heart Views serves as an essential platform for sharing innovative ideas and practices, thereby contributing to improved patient care and outcomes in the dynamic field of heart health.